Hypothesis: Cohesin-Dependent Loop Extrusion Underlies Accessibility Erosion in Aged Stem Cells

Core Idea Aged stem cells lose chromatin accessibility at distal enhancers not only because of histone mark changes but because cohesin-mediated loop extrusion fails, weakening enhancer-promoter contacts and making those regions prone to nucleosome closure.

Mechanistic Chain

1. Inflammatory signaling (e.g., TNF-alpha, IL-6) rises with age → NAD+ depletion → reduced SIRT1 deacetylase activity.
2. Hyperacetylation of cohesin subunits (SMC1A, SMC3) decreases their DNA binding affinity and stabilizes WAPL-mediated release.
3. Fewer cohesin complexes remain bound to CTCF sites, impairing loop extrusion and causing loss of topologically associating domain (TAD) boundaries at enhancer-rich regions.
4. Enhancers become physically disconnected from target promoters, leading to reduced transcriptional bursting and compensatory nucleosome packing, observed as ATAC-seq peak loss.
5. The resulting transcriptional noise and lineage-specific dysregulation drive functional decline in MuSCs, HSCs, and other stem compartments.

Novel Angles

• Links inflammation-induced metabolic stress directly to architectural protein dysfunction.
• Positions cohesin loss as a primary upstream event that secondarily alters histone modifications (e.g., reduced H3K27ac) rather than a downstream consequence.
• Explains why distal enhancers are especially vulnerable: they rely most on looping for activity, whereas promoters retain some accessibility via TF-driven nucleosome displacement.

Testable Predictions

• Cohesin occupancy: ChIP-seq for RAD21 or SMC3 in young vs. aged MuSCs/HSCs will show a selective decrease at distal enhancer loci that overlap lost ATAC-seq peaks 1.
• Rescue by NAD+ boosters: Treating aged stem cells with nicotinamide riboside will increase SIRT1 activity, restore cohesin binding, and partially recover ATAC-seq signal at enhancers without altering global histone marks.
• Cohesin overexpression: Lentiviral expression of an acetylation-resistant SMC3 mutant in aged cells will prevent accessibility erosion and improve proliferative capacity, mimicking young phenotypes.
• Causality test: Acute degron-mediated depletion of cohesin in young stem cells will reproduce the aged ATAC-seq erosion pattern and transcriptional noise, even in the absence of inflammatory cues.
• Discriminating silencers: Integrating cohesin ChIP-seq with ATAC-seq and H3K27ac will distinguish true enhancer loss (cohesin & H3K27ac down) from silencer gain (cohesin loss but H3K27me3 up), addressing a key technical caveat mentioned in the context.

Experimental Outline

1. Isolate quiescent MuSCs and short-term HSCs from young (3 mo) and old (24 mo) mice.
2. Perform ATAC-seq, RAD21 ChIP-seq, and H3K27ac/H3K27me3 ChIP-seq.
3. Quantify overlap of lost peaks with cohesin binding sites; compute correlation coefficients.
4. Intervention arms: NAD+ booster, cohesin mutant overexpression, control.
5. Functional assays: colony-forming unit, transplantation, muscle regeneration.

Potential Outcomes

• If cohesin loss precedes accessibility decline, the hypothesis is supported.
• If ATAC-seq loss occurs without cohesin changes, the model is falsified, pointing to alternative mechanisms (e.g., direct nucleosome remodeler inhibition).
• Successful rescue by NAD+ or cohesin mutants would provide a mechanistic bridge between inflammation, metabolism, and genome architecture in stem-cell aging.

Implications Validating this model would shift focus from histone-centric views to structural genome maintenance, suggesting that therapies targeting NAD+ metabolism or cohesin stability could broadly rejuvenate diverse stem cell types by preserving enhancer accessibility.